Data

India: Claims that Covid emergency relief is not reaching those in need

Thu, 2021-05-06 10:06 — mike kraft

India Covid aid: Is emergency relief reaching those in need? Emergency relief is flowing into India but concerns are mounting about delays in supply. BBC News

As India's devastating Covid-19 crisis mounted last month, countries around the world began sending emergency medical supplies to help stem the surge.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about India: Claims that Covid emergency relief is not reaching those in need
1 comment
Log in or register to post comments

CDC data shows the U.S. "Turning the Corner" Fueling hope and relaxation

Thu, 2021-05-06 09:53 — mike kraft

After weeks of coronavirus patients flooding emergency rooms in Michigan, the worst Covid-19 hot spot in the nation, hospitalizations are finally falling.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about CDC data shows the U.S. "Turning the Corner" Fueling hope and relaxation
Log in or register to post comments

OPINION: India, Brazil and the COVID cost of sidelining science

Wed, 2021-05-05 21:16 — mike kraft

India, Brazil and the human cost of sidelining science Governments that ignore or delay acting on scientific advice are missing out on a crucial opportunity to control the pandemic. nature

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about OPINION: India, Brazil and the COVID cost of sidelining science
Log in or register to post comments

Novavax vaccine study: 51% efficacy against South African variant

Wed, 2021-05-05 19:36 — mike kraft

Novavax vaccine shows 51% efficacy against South African variant, study finds Novavax Inc's (NVAX.O) COVID-19 vaccine had efficacy of 51% against infections caused by the South African variant among people who were HIV negative, and 43% in a group that included people who were HIV positive, according to a new analysis published on Wednesday. Julie Steenhuysen Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Novavax vaccine study: 51% efficacy against South African variant
Log in or register to post comments

OVERVIEW: Rich countries to address unequal global vaccine rollout, and other developments

Wed, 2021-05-05 10:08 — mike kraft

Covid-19 live updates: Club of rich countries to address unequal global vaccine rollout According to the World Health Organization, of the 832 million vaccine doses administered around the world by mid-April, just 0.2% were given in lower-income countries. Jennifer Hassan, Paul Schemm, Lateshia Beachum Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: Rich countries to address unequal global vaccine rollout, and other developments
Log in or register to post comments

CDCcompiles data on the rates of side effects after dose of Moderna and Pfizer’s vaccines

Tue, 2021-05-04 20:28 — mike kraft

How Common Are Your Covid-19 Vaccine Side Effects? New data from the CDC shows the rates of side effects after each dose of Moderna and Pfizer’s vaccines Theresa Machemer Smithsonian Magazine

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about CDCcompiles data on the rates of side effects after dose of Moderna and Pfizer’s vaccines
Log in or register to post comments

Vaccines linked to rare clotting disorders--an analysis

Tue, 2021-05-04 20:01 — mike kraft

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Vaccines linked to rare clotting disorders--an analysis
Log in or register to post comments

European regulators are reviewing use of Pfizer vaccine for adolescents

Mon, 2021-05-03 15:08 — mike kraft

European regulators reviewing Pfizer vaccine for adolescents European drug regulators are reviewing a request by Pfizer and BioNTech to extend the use of their coronavirus vaccine to children as young as 12 years old. Nathaniel Weixel TheHill

European drug regulators are reviewing a request by Pfizer and BioNTech to extend the use of their coronavirus vaccine to children as young as 12 years old.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?: